According to Scribe Therapeutics's latest financial reports the company's current revenue (TTM ) is C$71.13 Million. In 2025 the company made a revenue of C$71.13 Million an increase over the revenue in the year 2024 that were of C$38.1 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.